• Je něco špatně v tomto záznamu ?

Chrysin-benzothiazole conjugates as antioxidant and anticancer agents

BM. Mistry, RV. Patel, YS. Keum, DH. Kim,

. 2015 ; 25 (23) : 5561-5. [pub] 20151020

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17000913

7-(4-Bromobutoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one, obtained from chrysin with 1,4-dibromobutane, was combined with a wide range of 6-substituted 2-aminobenzthiazoles, which had been prepared from the corresponding anilines with potassium thiocyanate. Free radical scavenging efficacies of newer analogues were measured using DPPH and ABTS assays, in addition to the assessment of their anticancer activity against cervical cancer cell lines (HeLa and CaSki) and ovarian cancer cell line (SK-OV-3) implementing the SRB assay. Cytotoxicity of titled compounds was checked using Madin-Darby canine kidney (MDCK) non-cancer cell line. Overall, 6a-r indicated remarkable antioxidant power as DPPH and ABTS(+) scavengers; particularly the presence of halogen(s) (6g, 6h, 6j-6l) was favourable with IC50 values comparable to the control ascorbic acid. Unsubstituted benzothiazole ring favored the activity of resultant compounds (6a and 6r) against HeLa cell line, whereas presence of chlorine (6g) or a di-fluoro group (6k) was a key to exert strong action against CaSki. Moreover, a mono-fluoro (6j) and a ketonic functionality (6o) were beneficial to display anticipated anticancer effects against ovarian cancer cell line SK-OV-3. The structural assignments of the new products were done on the basis of IR, (1)H NMR, (13)C NMR spectroscopy and elemental analysis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17000913
003      
CZ-PrNML
005      
20170113113924.0
007      
ta
008      
170103s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bmcl.2015.10.052 $2 doi
024    7_
$a 10.1016/j.bmcl.2015.10.052 $2 doi
035    __
$a (PubMed)26514745
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Mistry, Bhupendra M $u Organic Research Laboratory, Department of Bioresources and Food Sciences, College of Life and Environmental Sciences, Konkuk University, Seoul, South Korea.
245    10
$a Chrysin-benzothiazole conjugates as antioxidant and anticancer agents / $c BM. Mistry, RV. Patel, YS. Keum, DH. Kim,
520    9_
$a 7-(4-Bromobutoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one, obtained from chrysin with 1,4-dibromobutane, was combined with a wide range of 6-substituted 2-aminobenzthiazoles, which had been prepared from the corresponding anilines with potassium thiocyanate. Free radical scavenging efficacies of newer analogues were measured using DPPH and ABTS assays, in addition to the assessment of their anticancer activity against cervical cancer cell lines (HeLa and CaSki) and ovarian cancer cell line (SK-OV-3) implementing the SRB assay. Cytotoxicity of titled compounds was checked using Madin-Darby canine kidney (MDCK) non-cancer cell line. Overall, 6a-r indicated remarkable antioxidant power as DPPH and ABTS(+) scavengers; particularly the presence of halogen(s) (6g, 6h, 6j-6l) was favourable with IC50 values comparable to the control ascorbic acid. Unsubstituted benzothiazole ring favored the activity of resultant compounds (6a and 6r) against HeLa cell line, whereas presence of chlorine (6g) or a di-fluoro group (6k) was a key to exert strong action against CaSki. Moreover, a mono-fluoro (6j) and a ketonic functionality (6o) were beneficial to display anticipated anticancer effects against ovarian cancer cell line SK-OV-3. The structural assignments of the new products were done on the basis of IR, (1)H NMR, (13)C NMR spectroscopy and elemental analysis.
650    _2
$a zvířata $7 D000818
650    _2
$a antitumorózní látky $x chemická syntéza $x chemie $x farmakologie $7 D000970
650    _2
$a antioxidancia $x chemická syntéza $x chemie $x farmakologie $7 D000975
650    _2
$a benzothiazoly $x chemická syntéza $x chemie $x farmakologie $7 D052160
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a psi $7 D004285
650    _2
$a preklinické hodnocení léčiv $7 D004353
650    _2
$a flavonoidy $x chemická syntéza $x chemie $x farmakologie $7 D005419
650    _2
$a HeLa buňky $7 D006367
650    _2
$a lidé $7 D006801
650    _2
$a inhibiční koncentrace 50 $7 D020128
650    _2
$a buňky MDCK $7 D061985
650    _2
$a molekulární struktura $7 D015394
655    _2
$a časopisecké články $7 D016428
700    1_
$a Patel, Rahul V $u Laboratory of Growth Regulators, Centre of the Region Haná for Biotechnological and Agricultural Research, Institute of Experimental Botany ASCR & Palacký University, Šlechtitelů 27, 783 71 Olomouc, Czech Republic. Electronic address: rahul.svnit11@gmail.com.
700    1_
$a Keum, Young-Soo $u Organic Research Laboratory, Department of Bioresources and Food Sciences, College of Life and Environmental Sciences, Konkuk University, Seoul, South Korea.
700    1_
$a Kim, Doo Hwan $u Organic Research Laboratory, Department of Bioresources and Food Sciences, College of Life and Environmental Sciences, Konkuk University, Seoul, South Korea.
773    0_
$w MED00000770 $t Bioorganic & medicinal chemistry letters $x 1464-3405 $g Roč. 25, č. 23 (2015), s. 5561-5
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26514745 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170113114025 $b ABA008
999    __
$a ok $b bmc $g 1180053 $s 961480
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 25 $c 23 $d 5561-5 $e 20151020 $i 1464-3405 $m Bioorganic & medicinal chemistry letters $n Bioorg Med Chem Lett $x MED00000770
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

Možnosti archivace